Last reviewed · How we verify
NCT03985527
Janus Feasibility Study
NA trial testing Transvenous nerve stimulation in Sleep Apnea Syndromes in 29 participants. Completed in 12 December 2025.
12 December 2025
Quick facts
| Lead sponsor | Respicardia, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 29 |
| Start date | 9 January 2020 |
| Primary completion | 12 December 2025 |
| Estimated completion | 12 December 2025 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Transvenous nerve stimulation
Conditions studied
- Sleep Apnea Syndromes — all drugs for Sleep Apnea Syndromes →
Sponsor
Respicardia, Inc.
Who can join
18 and older, any sex, with Sleep Apnea Syndromes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this feasibility study is to assess whether an alternative transvenous lead location affects respiration and airway physiology during a commercial remedē® System or commercial transvenous cardiac device (de novo pacemaker or implantable cardiac defibrillator) implant procedure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03985527
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sleep Apnea Syndromes
Currently open trials in the same condition.
- NCT06578390 — Efficacy Investigation of the Medical Device Apneal® on Smartphone for Sleep Apnea-Hypopnea Syndrome Diagnosis · NA · recruiting
- NCT07086599 — Typological Study of Sleep Pathologies During Psoriatic Rheumatism and SAPHO Syndrome: Prospective Study Within the Pari · recruiting
- NCT04399200 — Apnea, Stroke and Incident Cardiovascular Events · recruiting
- NCT04234828 — Validation of Withings Sleep for the Detection of Sleep Apnea Syndrome · active not recruiting
Other Respicardia, Inc. trials
Trials by the same sponsor.
- NCT03884660 — remedē System Therapy Study · active not recruiting
- NCT03425188 — Post Approval Study of the remedē System · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03985527 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Respicardia, Inc.
- Last refreshed: 30 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03985527.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing